|Titre :||Drug use changes at the individual level: Results from a longitudinal, multisite survey in young Europeans frequenting the nightlife scene (2022)|
|Auteurs :||M. GRABSKI ; J. WALDRON ; T. P. FREEMAN ; C. MOKRYSZ ; R. J. J. VAN BEEK ; P. VAN DER POL ; B. HAUSPIE ; N. DIRKX ; J. SCHROOTEN ; T. H. ELGAN ; K. FELTMAN ; E. BENEDETTI ; G. SCALIA TOMBA ; F. FABI ; S. MOLINARO ; J. GRIPENBERG ; T. VAN HAVERE ; M. VAN LAAR ; H. V. CURRAN|
|Type de document :||Article : Périodique|
|Dans :||European Addiction Research (Vol.28, n°2, March 2022)|
|Article en page(s) :||155-160|
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus GéographiqueEUROPE ; BELGIQUE ; ITALIE ; PAYS-BAS ; SUEDE ; ROYAUME-UNI
Thésaurus TOXIBASEETUDE LONGITUDINALE ; MILIEU FESTIF ; JEUNE ; KETAMINE ; DROGUES DE SYNTHESE ; OPIOIDES ; EVOLUTION ; PREVALENCE
BACKGROUND: Monitoring emerging trends in the increasingly dynamic European drug market is vital; however, information on change at the individual level is scarce. In the current study, we investigated changes in drug use over 12 months in European nightlife attendees.
METHOD: In this longitudinal online survey, changes in substances used, use frequency in continued users, and relative initiation of use at follow-up were assessed for 20 different substances. To take part, participants had to be aged 18-34 years; be from Belgium, Italy, the Netherlands, Sweden, or the UK; and have attended at least 6 electronic music events in the past 12 months at baseline. Of 8,045 volunteers at baseline, 2,897 completed the survey at both time points (36% follow-up rate), in 2017 and 2018.
RESULTS: The number of people using ketamine increased by 21% (p < 0.001), and logarithmized frequency of use in those continuing use increased by 15% (p < 0.001; 95% CI: 0.07-0.23). 4-Fluoroamphetamine use decreased by 27% (p < 0.001), and logarithmized frequency of use in continuing users decreased by 15% (p < 0.001, 95% CI: -0.48 to -0.23). The drugs with the greatest proportion of relative initiation at follow-up were synthetic cannabinoids (73%, N = 30), mephedrone (44%, N = 18), alkyl nitrites (42%, N = 147), synthetic dissociatives (41%, N = 15), and prescription opioids (40%, N = 48).
CONCLUSIONS: In this European nightlife sample, ketamine was found to have the biggest increase in the past 12 months, which occurred alongside an increase in frequency of use in continuing users. The patterns of uptake and discontinuation of alkyl nitrates, novel psychoactive substances, and prescription opioids provide new information that has not been captured by existing cross-sectional surveys. These findings demonstrate the importance of longitudinal assessments of drug use and highlight the dynamic nature of the European drug landscape.
|Domaine :||Autres substances / Other substances ; Drogues illicites / Illicit drugs|
|Refs biblio. :||11|
Clinical Psychopharmacology Unit, University College London, London, UK
Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK